Award regulars Danaher and Medtronic are each up for four awards at the IR Magazine Awards – US 2021, in a year when 13 different healthcare and pharmaceutical companies share 21 nominations.
The only other company to boast four award nods is Axon Enterprise, the Arizona-based inventor of the tazer, which develops technology and weapons products for the military, law enforcement and civilians. Axon is in the running for best overall investor relations (mid-cap), best investor relations officer (small to mid-cap) for Andrea James, most progress in IR and best IR in the consumer discretionary sector.
Danaher and Medtronic are up against each other in a number of categories, including the prestigious best overall investor relations (large cap) category and best investor relations officer (large cap) award for Matthew Gugino of Danaher and Ryan Weispfenning of Medtronic.
Equinix, Microsoft and Nvidia are also in the running for the best overall investor relations (large cap) award, while Gugino and Weispfenning are up against Elena Rosman from Aptiv and Jill Slattery from Hilton Worldwide for the best large-cap IRO gong.
Winners will be announced at the virtual awards ceremony on Thursday, March 25. The event is free to attend and open to all IR professionals. Click here to register now.
A total of 28 awards will be given out on the night, including a lifetime achievement award as a special recognition to a seasoned IR professional. The majority of winners are determined by the investment community, with IR Magazine surveying hundreds of analysts and portfolio managers to find out which companies really shone over the past year.
This year, there are seven self-nomination awards, where winners are chosen by a panel of judges. The judges for the 2021 awards are: Ben Ashwell, editor of IR Magazine, Sally Curley, founder and CEO of Curley Global IR, William Galligan, former vice president of investor relations at Kansas City Southern, Gary LaBranche, president and CEO of NIRI, and Carol Murray-Negron, president of Equanimity.